feed,title,long_url,short_url
Benzinga,Unusual Options Activity Insight: Boeing,https://www.benzinga.com/markets/options/20/09/17352648/unusual-options-activity-insight-boeing,https://j.mp/34ZbPQi
Benzinga,Price Over Earnings Overview: Kandi Technologies,https://www.benzinga.com/news/earnings/20/09/17352636/price-over-earnings-overview-kandi-technologies,https://j.mp/31SDNLv
Benzinga,Understanding Biomarin Pharmaceutical's Unusual Options Activity,https://www.benzinga.com/general/health-care/20/09/17352623/understanding-biomarin-pharmaceuticals-unusual-options-activity,https://j.mp/2ZfWC9V
Benzinga,Understanding Facebook's Unusual Options Activity,https://www.benzinga.com/markets/options/20/09/17352605/understanding-facebooks-unusual-options-activity,https://j.mp/35auzfR
Benzinga,Unusual Options Activity Insight: IBM,https://www.benzinga.com/markets/options/20/09/17352557/unusual-options-activity-insight-ibm,https://j.mp/2F13UGV
Benzinga,Could DocuSign And CrowdStrike Follow Zoom's Earnings Footsteps?,https://www.benzinga.com/markets/20/09/17352155/could-docusign-and-crowdstrike-follow-zooms-earnings-footsteps,https://j.mp/2QJL3D0
